Mantleoma: Difference between revisions
CSV import |
CSV import |
||
| Line 53: | Line 53: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Revision as of 03:38, 11 February 2025
Mantleoma is a rare type of cancer that originates from the mantle cells of the lymphatic system. This type of cancer is characterized by the uncontrolled growth and spread of abnormal cells in the mantle zone of the lymph nodes.
Symptoms
The symptoms of mantleoma can vary depending on the stage of the disease and the individual's overall health. Common symptoms may include:
Causes
The exact cause of mantleoma is unknown. However, it is believed to be associated with a genetic mutation in the cyclin D1 gene. This mutation leads to the overproduction of cyclin D1 protein, which promotes cell growth and division.
Diagnosis
Diagnosis of mantleoma typically involves a combination of physical examination, medical history, and laboratory tests. These may include:
- Biopsy of the affected lymph node
- Blood tests
- Imaging tests such as CT scan or MRI
- Bone marrow biopsy
Treatment
Treatment for mantleoma depends on the stage of the disease, the patient's overall health, and their personal preferences. Treatment options may include:
Prognosis
The prognosis for individuals with mantleoma varies widely. Factors that can affect prognosis include the stage of the disease at diagnosis, the individual's overall health, and the response to treatment.
See also
References
<references />


